Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228228 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 9 Pages |
Abstract
In patients with locally advanced disease, who were clinically node-positive at presentation, BCS after NCT resulted in acceptably low rates of IBTR and LRR. Mastectomy should be considered as an option in patients who present with clinical stage III tumors or who are not treated with adjuvant hormone suppression therapy, because they exhibit high IBTR rates after NCT and BCS.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sun Young M.D, Seung Ju M.D., Kyung Hwan M.D., In Hae M.D., So-Youn M.D., Keun Seok M.D., Jungsil M.D., Seeyoun M.D., Seok Won M.D., Tae Hyun M.D., Han-Sung M.D., Kwan Ho M.D.,